![Michael Kaseta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kaseta
Finanzdirektor/CFO bei
LIQUIDIA CORPORATION
Vermögen: 28 Mio $ am 30.06.2026
Profil
Michael Kaseta currently works at Bryn Pharma LLC, as Director from 2023, Heron Therapeutics, Inc., as Independent Director from 2024, Liquidia Corp., as Chief Financial & Operating Officer from 2024, and Liquidia Technologies, Inc., as Chief Financial & Operating Officer from 2020.
Mr. Kaseta also formerly worked at Alimera Sciences, Inc., as Independent Director from 2023 to 2024, Sanofi, as Chief Financial Officer-Sanofi North America from 2015 to 2016, Aerami Therapeutics, Inc., as Chief Financial Officer from 2019 to 2020, and Old API Wind-down Ltd., as Chief Financial & Accounting Officer from 2018 to 2019.
Mr. Kaseta received his undergraduate degree from James Madison University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0.39% | 13.07.2026 | 345’805 ( 0.39% ) | 28 Mio $ | 30.06.2026 |
| 14.04.2026 | 29’787 ( 0.02% ) | 12 719 $ | 30.06.2026 |
Aktive Positionen von Michael Kaseta
| Unternehmen | Position | Beginn |
|---|---|---|
| LIQUIDIA CORPORATION | Finanzdirektor/CFO | 30.11.2020 |
| HERON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 04.11.2024 |
Bryn Pharma LLC
 Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Direktor/Vorstandsmitglied | 02.05.2023 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Finanzdirektor/CFO | 20.08.2020 |
Ehemalige bekannte Positionen von Michael Kaseta
| Unternehmen | Position | Ende |
|---|---|---|
| ALIMERA SCIENCES, INC. | Direktor/Vorstandsmitglied | 16.09.2024 |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Finanzdirektor/CFO | 01.11.2020 |
| OLD API WIND-DOWN LTD. | Finanzdirektor/CFO | 01.01.2019 |
| SANOFI | Corporate Officer/Principal | 01.09.2016 |
Ausbildung von Michael Kaseta
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
James Madison University
 James Madison University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Wählen Sie MarketScreener 
